Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population advanced non-small cell lung cancer still matter of debate?—An update incorporating the DELTA trial data

Benzer Materyaller

• Gun Control in the UK—Still a Matter for Debate
  Yazar:: Sharp, David
  Baskı/Yayın Bilgisi: (2006)
• Second-line treatment in EGFR-unselected patients: is it time to close one arm of this river’s DELTA?
  Yazar:: Morales-Espinosa, Daniela, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Update on third-generation EGFR tyrosine kinase inhibitors
  Yazar:: Gray, Jhanelle, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles
  Yazar:: Zanetti-Domingues, Laura C., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Neutral Cholesterol Ester Hydrolases in Macrophages: Still a Matter of Debate
  Yazar:: Kratky, Dagmar
  Baskı/Yayın Bilgisi: (2011)